Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dina Lev

Showing results (31-40 of 109) with videos related to

Pageof 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Increased vascular endothelial growth factor-C expression is insufficient to induce lymphatic metastasis in human soft-tissue sarcomasGuy Lahat, Alexander Lazar, Xuemei Wang, et al.
Cancer Research|April 17, 2008
Soft tissue sarcoma cells are highly sensitive to AKT blockade: a role for p53-independent up-regulation of GADD45 alphaQuan-Sheng Zhu, Wenhong Ren, Borys Korchin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Epidermal growth factor receptor blockade in combination with conventional chemotherapy inhibits soft tissue sarcoma cell growth in vitro and in vivoWenhong Ren, Borys Korchin, Quan-Sheng Zhu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 5, 2014
The value of ¹⁸F-FDG PET/CT in the management of malignant peripheral nerve sheath tumorsBenjapa Khiewvan, Homer A Macapinlac, Dina Lev, et al.
Histopathology|December 17, 2009
Validation of potential therapeutic targets in alveolar soft part sarcoma: an immunohistochemical study utilizing tissue microarrayAlexander J Lazar, Guy Lahat, Sarah E Myers, et al.
Histopathology|September 3, 2011
'Difficult to diagnose' desmoid tumours: a potential role for CTNNB1 mutational analysisChiara Colombo, Svetlana Bolshakov, Shohrae Hajibashi, et al.
Histopathology|November 1, 2011
The expression of c-Met pathway components in unclassified pleomorphic sarcoma/malignant fibrous histiocytoma (UPS/MFH): a tissue microarray studyGuy Lahat, Pingyu Zhang, Quan-Sheng Zhu, et al.
Cancer Research|June 5, 2007
ACTIBIND, a T2 RNase, competes with angiogenin and inhibits human melanoma growth, angiogenesis, and metastasisBetty Schwartz, Oded Shoseyov, Vladislava O Melnikova, et al.
Molecular Cancer Therapeutics|March 4, 2010
Doxorubicin resistance in a novel in vitro model of human pleomorphic liposarcoma associated with alternative lengthening of telomeresMarcy A Mitchell, Jay E Johnson, Kara Pascarelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Midkine enhances soft-tissue sarcoma growth: a possible novel therapeutic targetZeming Jin, Guy Lahat, Borys Korchin, et al.
Pageof 11

Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Increased vascular endothelial growth factor-C expression is insufficient to induce lymphatic metastasis in human soft-tissue sarcomasGuy Lahat, Alexander Lazar, Xuemei Wang, et al.
Cancer Research|April 17, 2008
Soft tissue sarcoma cells are highly sensitive to AKT blockade: a role for p53-independent up-regulation of GADD45 alphaQuan-Sheng Zhu, Wenhong Ren, Borys Korchin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
Epidermal growth factor receptor blockade in combination with conventional chemotherapy inhibits soft tissue sarcoma cell growth in vitro and in vivoWenhong Ren, Borys Korchin, Quan-Sheng Zhu, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 5, 2014
The value of ¹⁸F-FDG PET/CT in the management of malignant peripheral nerve sheath tumorsBenjapa Khiewvan, Homer A Macapinlac, Dina Lev, et al.
Histopathology|December 17, 2009
Validation of potential therapeutic targets in alveolar soft part sarcoma: an immunohistochemical study utilizing tissue microarrayAlexander J Lazar, Guy Lahat, Sarah E Myers, et al.
Histopathology|September 3, 2011
'Difficult to diagnose' desmoid tumours: a potential role for CTNNB1 mutational analysisChiara Colombo, Svetlana Bolshakov, Shohrae Hajibashi, et al.
Histopathology|November 1, 2011
The expression of c-Met pathway components in unclassified pleomorphic sarcoma/malignant fibrous histiocytoma (UPS/MFH): a tissue microarray studyGuy Lahat, Pingyu Zhang, Quan-Sheng Zhu, et al.
Cancer Research|June 5, 2007
ACTIBIND, a T2 RNase, competes with angiogenin and inhibits human melanoma growth, angiogenesis, and metastasisBetty Schwartz, Oded Shoseyov, Vladislava O Melnikova, et al.
Molecular Cancer Therapeutics|March 4, 2010
Doxorubicin resistance in a novel in vitro model of human pleomorphic liposarcoma associated with alternative lengthening of telomeresMarcy A Mitchell, Jay E Johnson, Kara Pascarelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2008
Midkine enhances soft-tissue sarcoma growth: a possible novel therapeutic targetZeming Jin, Guy Lahat, Borys Korchin, et al.
Pageof 11